^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    miR-503-5p overexpression

    i
    Other names: MIR503, MicroRNA 503, Hsa-MiR-503-5p, Hsa-Mir-503, MIR503, Hsa-MiR-503-3p, Hsa-Mir-15-P2d, MIRN503, Mir-503
    Entrez ID:
    574506
    Related biomarkers:
    Expression
    almost2years
    Downregulation of miR-503-5p Promotes the Development of Pancreatic Cancer by Targeting Cyclin E2. (PubMed, Crit Rev Immunol)
    The downregulation of miR-503-5p enhances the progression of PC by targeting CCNE2. The detection of miR-503-5p expression may provide valuable insights for the prevention and prognostic evaluation of PC.
    Journal
    |
    CCNE2 (Cyclin E2) • MIR503 (MicroRNA 503)
    |
    miR-503-5p overexpression • miR-503 expression
    almost4years
    Repression of lncRNA PART1 attenuates ovarian cancer cell viability, migration and invasion through the miR-503-5p/FOXK1 axis. (PubMed, BMC Cancer)
    Decreased PART1 represses the cell viability, migration and invasion of OC via regulating the miR-503-5p/FOXK1 axis, which provided an underlying target for treating OC.
    Journal
    |
    MIR503 (MicroRNA 503)
    |
    miR-503-5p overexpression